ReviewFrontiers in pharmacology2022

A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy.

Valeria Botti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.